Pliant Therapeutics, Inc. (PLRX) Tops Q3 EPS by 13c

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q3 EPS of ($0.43), $0.13 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Morgan Stanley Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Overweight
• Morgan Stanley Resumes OMV AG (OMV:AV) (OMVKY) at Equalweight